Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-18T17:27:59.086Z Has data issue: false hasContentIssue false
  • English
  • Français

Multiple skin testing of tuberculosis patients with a range of new tuberculins, and a comparison with leprosy and Mycobacterium ulcerans infection

Published online by Cambridge University Press:  15 May 2009

M. J. Shield ,
J. L. Stanford ,
R. C. Paul  and
J. W. Carswell
M. J. Shield
Affiliation:
Middlesex Hospital Medical School, Riding House Street, London W1P 7LD
J. L. Stanford
Affiliation:
Middlesex Hospital Medical School, Riding House Street, London W1P 7LD
R. C. Paul
Affiliation:
Middlesex Hospital Medical School, Riding House Street, London W1P 7LD
J. W. Carswell
Affiliation:
Department of Surgery, Mulago Hospital, P.O. Box 7051, Kampala
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Four hundred and seventy tuberculosis patients were each skin tested with four of a range of 17 mycobacterial reagents in four countries in all of which tuberculosis and leprosy were endemic. Sixteen of the reagents were new tuberculins prepared from extracts of living mycobacteria disrupted by ultrasonic disintegration and the last was PPD, RT23.

The effect that tuberculosis exerted on the delayed-type skin test response to these antigens was assessed by comparing results for tuberculosis patients with those for Tuberculin positive and Tuberculin negative control populations. Tuberculosis patients on Rifampicin therapy showed no difference in their skin test responses to any of the antigens from those patients on other forms of anti-tuberculosis treatment.

Amongst the normal population it was found that possession of Tuberculin positivity was associated with an enhanced response to all the other mycobacterial antigens with the exception of A*-in which demonstrated a reciprocal relationship with Tuberculin in Burma. It was also noted, in Burma particularly, that sensitization to mycobacterial species other than Mycobacterium tuberculosis, especially to the slow growers, plays a role in determining responses to different mycobacterial species.

In tuberculosis patients enhanced skin test responses were also seen but only in those countries, e.g. Libya, where the prevalence of mycobacterial species was low. Where mycobacteria were common, as in Burma, the converse was true and tuberculosis was associated with a diminished skin test response to each antigen. The high prevalence of A*-in positivity in Burma, its reciprocal relationship with Tuberculin there and the results for all the antigens in the tuberculosis patients indicate that the cell mediated skin test response may have a threshold. If this is exceeded the skin test becomes negative so that non-reactors then include those who have been excessively sensitized as well as those who have not been sensitized. Despite this, a greater percentage of tuberculosis patients in each country responded to the specific reagent Tuberculin than did the control populations and their mean positive induration sizes were consistently larger. Nevertheless, amongst the tuberculosis patients in Burma 13% were complete non-reactors to Tuberculim and this apparent anergy also applied to the other reagents with which these individuals were tested.

This differs from lepromatous leprosy where the anergic state pertain exclusively to M. leprae and a few seemingly closely related species. The breadth of anergy in M. ulcerans infection has not been measured but it is known to effect both Burulin and the PPD, RT23.

Just as in leprosy and M. ulcerans infection, tuberculosis can be shown to have a disease spectrum here detected by multiple skin testing. The significance of this spectrum and its similarities with and differences from that of the other mycobacterioses is discussed.

Type
Research Article
Information
Journal of Hygiene , Volume 78 , Issue 3 , June 1977 , pp. 331 - 348
Copyright
Copyright © Cambridge University Press 1977

References

REFERENCES

Burma Ministry of Health (1974). Tuberculosis baseline survey in Burma in 1972. (Summarized in Tubercle 55, 313–25.)Google Scholar
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265–75.CrossRefGoogle ScholarPubMed
Magnusson, M. (1961). Specificity of Mycobacterial sensitins. 1. Studies in guinea pigs with purified ‘tuberculin’ prepared from mammalian and avian tubercle bacilli, Mycobacterium balnei and other acid fast bacilli. American Review of Respiratory Diseases 83, 69–84.Google Scholar
Nilsson, B. S. (1971). Rifampicin: An Immunosuppressant? Lancet ii, 374.Google Scholar
Paul, R. C., Stanford, J. L., Misljenóvic, O. & Lefering, J. (1975 a). Multiple skin testing of Kenyan schoolchildren with a series of new tuberculins. Journal of Hygiene 75, 303–13.Google Scholar
Paul, R. C., Stanford, J. L. & Carswell, J. W. (1975). Multiple skin testing in leprosy. Journal of Hygiene 75, 57–68.CrossRefGoogle ScholarPubMed
Pa˘unescu, E. (1970). In vivo and in vitro suppression of humoral and cellular immunological response by Rifampicin. Nature, London 228, 1188–90.Google Scholar
Ridley, D. S. & Jopling, W. H. (1966). Classification of leprosy according to immunity. A five group system. International Journal of Leprosy 34, 225–73.Google ScholarPubMed
Rook, G. A. W. (1973). Is the macrophage the site of the immunosuppressive action of Rifampicin? Tubercle 54, 291–5.CrossRefGoogle ScholarPubMed
Rook, G. A. W. (1975 a). The immunological consequence of antigen overload in experimental mycobacterial infections of mice. Clinical Experimental Immunology 19, 167–77.Google ScholarPubMed
Rook, G. A. W. (1975 b). The potentiating, mitogenic and inhibitory effect on lymphocytes in vitro, of macrophages in the lymph nodes of mice ‘overloaded’ with mycobacterial products. Clinical Experimental Immunology 21, 163–72.Google ScholarPubMed
Rook, G. A. W., Carswell, J. W. & Stanford, J. L. (1976). Preliminary evidence for the trapping of antigen-specific lymphocytes in the lymphoid tissue of ‘anergic’ tuberculosis patients. Clinical Experimental Immunology 26, 129–32.Google Scholar
Runyon, E. H. (1976). Tuberculins and other Mycobacterins. Editorial; American Review of Respiratory Diseases 113, 715.Google Scholar
Stanford, J. L. & Paul, R. C. (1973). A preliminary report on some studies of environmental mycobacteria from Uganda. Annales de la Société belge de Médecin tropicale 53, 389–93.Google Scholar
Stanford, J. L., Paul, R. C., Penketh, A., Thurlow, S., Carswell, J. W., Barker, D. J. P. & Barot, S. (1976 a). A preliminary study of the effect of contact with environmental mycobacteria on the pattern of sensitivity to a range of new Tuberculins amongst Ugandan adults. Journal of Hygiene 76, 205–14.Google Scholar
Stanford, J. L., Revill, W. D. L., Gunthorp, W. J. & Grange, J. M. (1975). The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection. Journal of Hygiene 74, 7–16.Google Scholar
Stanford, J. L. & Rook, G. A. W. (1976). Taxonomic studies of the leprosy bacillus. International Journal of Leprosy 44, 216–27.Google Scholar
Stanford, J. L., Shield, M. J., Paul, R. C., Kahlil, A., Tobgi, R. S. & Wallace, A. (1976 b). The effect of desert conditions on the reactivity of Libyan schoolchildren to a range of new tuberculins. Journal of Hygiene 77, 63–75.Google Scholar